Toews Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Toews Corporation’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,500	Closed	-$784K	–	26
2023 Q3	$784K	Buy	+13,500	New	+$827K	0.47%	15
2023 Q1	–	Sell	-10,500	Closed	-$755K	–	31
2022 Q4	$755K	Sell	10,500 -6,700	-39%	-$505K	0.37%	100
2022 Q3	$1.22M	Buy	17,200 +700	+4%	+$50.8K	0.9%	3
2022 Q2	$1.27M	Buy	16,500 +11,100	+206%	+$845K	0.85%	11
2022 Q1	$394K	Buy	+5,400	New	+$363K	0.07%	104
2021 Q4	–	Sell	-6,800	Closed	-$402K	–	38
2021 Q3	$402K	Buy	+6,800	New	+$448K	0.05%	97
2021 Q2	–	Sell	-14,800	Closed	-$934K	–	31
2021 Q1	$934K	Buy	+14,800	New	+$921K	0.08%	90
2020 Q4	–	Sell	-16,700	Closed	-$1.01M	–	36
2020 Q3	$1.01M	Buy	+16,700	New	+$1.01M	0.31%	30

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Toews Corporation's BMY Position: Q4 2023 in Review

Toews Corporation sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 13,500 shares — an estimated $784K sold.

Toews Corporation first reported a position in BMY in Q3 2020 and held it in 8 quarters. The position peaked at $1.27M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Toews Corporation reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Toews Corporation sold 13,500 Bristol-Myers Squibb shares in Q4 2023, an estimated $784K.
Toews Corporation first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 8 quarters.
Toews Corporation's Bristol-Myers Squibb position peaked at $1.27M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.